Whole-genome landscape of adult T-cell leukemia/lymphoma.
Yasunori KogureTakuro KamedaJunji KoyaMakoto YoshimitsuKisato NosakaJun-Ichirou YasunagaYoshitaka ImaizumiMizuki WatanabeYuki SaitoYuta ItoMarni B SiegelMariko TabataSumito ShingakiKota YoshifujiKenichi ChibaAi OkadaNobuyuki KakiuchiYasuhito NannyaAyako KamiuntenYuki TahiraKeiichi AkizukiMasaaki SekineKotaro ShideTomonori HidakaYoko KubukiAkira KitanakaMichihiro HidakaNobuaki NakanoAtae UtsunomiyaR Alejandro SicaAna Acuna-VillaordunaMurali JanakiramUrvi A ShahJuan Carlos RamosTatsuhiro ShibataKengo TakeuchiAkifumi Takaori-KondoYasushi MiyazakiMasao MatsuokaKenji IshitsukaYuichi ShiraishiSatoru MiyanoSeishi OgawaB Hilda YeKazuya ShimodaKeisuke KataokaPublished in: Blood (2021)
Adult T-cell leukemia/lymphoma (ATL) is an aggressive neoplasm immunophenotypically resembling regulatory T cells, associated with human T-cell leukemia virus type-1. Here we performed whole-genome sequencing (WGS) of 150 ATL cases to reveal the overarching landscape of genetic alterations in ATL. We discovered frequent (33%) loss-of-function alterations preferentially targeting the CIC long isoform, which were overlooked by previous exome-centric studies of various cancer types. Long but not short isoform-specific inactivation of Cic selectively increased CD4+CD25+Foxp3+ T cells in vivo. We also found recurrent (13%) 3'-truncations of REL, which induce transcriptional upregulation and generate gain-of-function proteins. More importantly, REL truncations are also common in diffuse large B-cell lymphoma, especially in germinal center B-cell-like subtype (12%). In the non-coding genome, we identified recurrent mutations in regulatory elements, particularly splice sites, of several driver genes. In addition, we characterized the different mutational processes operative in clustered hypermutation sites within and outside immunoglobulin/T-cell receptor genes and identified the mutational enrichment at the binding sites of host and viral transcription factors suggesting their activities in ATL. By combining the analyses for coding and non-coding mutations, structural variations, and copy number alterations, we discovered 56 recurrently altered driver genes, including 11 novel ones. Finally, ATL cases were classified into two molecular groups with distinct clinical and genetic characteristics based on the driver alteration profile. Our findings not only help to improve diagnostic and therapeutic strategies in ATL, but also provide insights into T-cell biology and have implications for genome-wide cancer driver discovery.
Keyphrases
- genome wide
- copy number
- diffuse large b cell lymphoma
- regulatory t cells
- dna methylation
- mitochondrial dna
- transcription factor
- acute myeloid leukemia
- papillary thyroid
- epstein barr virus
- bone marrow
- childhood cancer
- squamous cell
- gene expression
- dendritic cells
- small molecule
- cancer therapy
- immune response
- young adults
- sars cov
- cell proliferation
- drug delivery
- low grade
- signaling pathway
- poor prognosis
- long non coding rna
- induced pluripotent stem cells
- high grade
- case control